Matthew Taylor
Stock Analyst at Jefferies
(3.28)
# 1,871
Out of 5,182 analysts
185
Total ratings
59.29%
Success rate
10.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $110 → $100 | $58.45 | +71.09% | 2 | Apr 22, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $220 → $190 | $149.52 | +27.07% | 5 | Feb 10, 2026 | |
| PEN Penumbra | Downgrades: Hold | $335 → $374 | $325.99 | +14.73% | 2 | Jan 16, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $95 → $105 | $68.50 | +53.28% | 3 | Dec 11, 2025 | |
| PODD Insulet | Maintains: Neutral | $320 → $355 | $182.87 | +94.13% | 16 | Nov 7, 2025 | |
| EW Edwards Lifesciences | Upgrades: Buy | $80 → $98 | $82.28 | +19.11% | 20 | Oct 29, 2025 | |
| SI Shoulder Innovations | Initiates: Buy | $19 | $12.80 | +48.44% | 1 | Aug 25, 2025 | |
| ABT Abbott Laboratories | Upgrades: Buy | $143 → $145 | $93.86 | +54.49% | 17 | Jul 18, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $14.21 | +5.56% | 7 | Apr 14, 2025 | |
| MDT Medtronic | Maintains: Sell | $75 → $76 | $81.90 | -7.20% | 17 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $107 → $121 | $178.51 | -32.22% | 9 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $3.90 | +258.97% | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $45 | $18.63 | +141.55% | 2 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $10 | $7.18 | +39.28% | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $58 → $53 | $10.74 | +393.48% | 2 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $22 → $24 | $12.07 | +98.84% | 2 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $345 | $321.43 | +7.33% | 14 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $115 → $130 | $82.80 | +57.00% | 8 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $12.36 | +61.81% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $85 | $36.79 | +131.04% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $90.74 | -17.35% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $245 | $217.14 | +12.83% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $62 | $17.94 | +245.60% | 8 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $135.52 | +54.96% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $9.35 | +28.34% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $59.32 | +110.72% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $466.64 | -55.00% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $96 | $61.29 | +56.63% | 3 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $7 | $5.16 | +35.66% | 1 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $16 | $10.98 | +45.72% | 2 | Jul 19, 2017 |
Boston Scientific
Apr 22, 2026
Maintains: Buy
Price Target: $110 → $100
Current: $58.45
Upside: +71.09%
Becton, Dickinson and Company
Feb 10, 2026
Maintains: Buy
Price Target: $220 → $190
Current: $149.52
Upside: +27.07%
Penumbra
Jan 16, 2026
Downgrades: Hold
Price Target: $335 → $374
Current: $325.99
Upside: +14.73%
GE HealthCare Technologies
Dec 11, 2025
Maintains: Buy
Price Target: $95 → $105
Current: $68.50
Upside: +53.28%
Insulet
Nov 7, 2025
Maintains: Neutral
Price Target: $320 → $355
Current: $182.87
Upside: +94.13%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Buy
Price Target: $80 → $98
Current: $82.28
Upside: +19.11%
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $19
Current: $12.80
Upside: +48.44%
Abbott Laboratories
Jul 18, 2025
Upgrades: Buy
Price Target: $143 → $145
Current: $93.86
Upside: +54.49%
InMode
Apr 14, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $14.21
Upside: +5.56%
Medtronic
May 24, 2024
Maintains: Sell
Price Target: $75 → $76
Current: $81.90
Upside: -7.20%
Jan 30, 2024
Downgrades: Hold
Price Target: $107 → $121
Current: $178.51
Upside: -32.22%
Jan 19, 2024
Initiates: Buy
Price Target: $14
Current: $3.90
Upside: +258.97%
Oct 2, 2023
Maintains: Buy
Price Target: $47 → $45
Current: $18.63
Upside: +141.55%
Jul 19, 2023
Initiates: Underperform
Price Target: $10
Current: $7.18
Upside: +39.28%
Jul 12, 2023
Upgrades: Buy
Price Target: $58 → $53
Current: $10.74
Upside: +393.48%
May 24, 2023
Maintains: Hold
Price Target: $22 → $24
Current: $12.07
Upside: +98.84%
May 2, 2023
Maintains: Buy
Price Target: $320 → $345
Current: $321.43
Upside: +7.33%
Mar 31, 2023
Upgrades: Hold
Price Target: $115 → $130
Current: $82.80
Upside: +57.00%
Oct 12, 2022
Initiates: Buy
Price Target: $20
Current: $12.36
Upside: +61.81%
Oct 12, 2022
Initiates: Hold
Price Target: $85
Current: $36.79
Upside: +131.04%
Oct 12, 2022
Initiates: Buy
Price Target: $75
Current: $90.74
Upside: -17.35%
Oct 12, 2022
Initiates: Hold
Price Target: $245
Current: $217.14
Upside: +12.83%
Oct 12, 2022
Initiates: Hold
Price Target: $62
Current: $17.94
Upside: +245.60%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $135.52
Upside: +54.96%
Oct 12, 2022
Initiates: Buy
Price Target: $12
Current: $9.35
Upside: +28.34%
Oct 12, 2022
Initiates: Buy
Price Target: $125
Current: $59.32
Upside: +110.72%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $466.64
Upside: -55.00%
Feb 24, 2022
Upgrades: Buy
Price Target: $96
Current: $61.29
Upside: +56.63%
Dec 17, 2021
Initiates: Neutral
Price Target: $7
Current: $5.16
Upside: +35.66%
Jul 19, 2017
Maintains: Equal-Weight
Price Target: $17 → $16
Current: $10.98
Upside: +45.72%